-
Mashup Score: 0
The US move and the Takeda agreement were contained in a larger update on the Silence’s progress, one in which chairman Iain Ross said the company was in “robust health” both financially and operationally
Source: Proactiveinvestors UKCategories: CardiologistsTweet
Silence Therapeutics unveils Takeda deal and unveils plans to create US subsidiary https://t.co/2m7t7ABEjx $SLN #RNAi